# Jasper Therapeutics, Inc.: Form 8-K, filed Mar 19, 2025

- Company: [Jasper Therapeutics, Inc.](/companies/jspr.md) (CIK 1788028)
- Form: 8-K
- Filed: 2025-03-19
- Accepted by EDGAR: Mar 19, 2025, 16:42 ET
- Period: 2025-03-14
- Accession: 0001213900-25-025123
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1788028/000121390025025123/ea0234885-8k_jasper.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1788028/000121390025025123/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 1.02: Termination of a material agreement
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1788028/000121390025025123/ea0234885-8k_jasper.htm

Filed Mar 19, 2025.
Source: SEC EDGAR, the filing index for accession 0001213900-25-025123. Last ingested by Listed: Nov 14, 2026, 21:17 ET. No prices; not investment advice.